Transcriptome profile of the murine macrophage cell response to Candida parapsilosis

Fungal Genetics and Biology

Volumn 65, Issue , 2014, Pages 48-56

  Németh, Tibor ^a   Tóth, Adél ^a   Hamari, Zsuzsanna ^a   Falus, András ^b   Éder, Katalin ^b   Vágvölgyi, Csaba ^a   Guimaraes, Allan J ^c   Nosanchuk, Joshua D ^c   Gácser, Attila ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Candida parapsilosis; Host response; Infection; Macrophages

Indexed keywords

CD83 ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 1BETA; MESSENGER RNA; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; CD137 ANTIGEN; TNFRSF9 PROTEIN, HUMAN; TRANSCRIPTOME;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDIASIS; CD83 GENE; CELL ADHESION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTRON TRANSPORT; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC CODE; HOST PATHOGEN INTERACTION; IL1B GENE; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PTGS2 GENE; TH1 CELL; TNFA GENE; TNFRSF9 GENE; TRANSCRIPTOMICS; ANIMAL; CANDIDA; CELL CULTURE; GENETICS; HUMAN; MACROPHAGE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD137; CANDIDA; CELLS, CULTURED; HUMANS; MACROPHAGES; MICE; PHAGOCYTOSIS; TRANSCRIPTOME;

EID: 84896118623     PISSN: 10871845     EISSN: 10960937     Source Type: Journal    
DOI: 10.1016/j.fgb.2014.01.006     Document Type: Article

References (38)

1. Barker K.S., et al. Coculture of THP-1 human mononuclear cells with Candida albicans results in pronounced changes in host gene expression. J. Infect. Dis. 2005, 192:901-912.
2. Benjamin D.K., et al. Candida bloodstream infection in neonates. Semin. Perinatol. 2003, 27:375-383.
3. Bertini A., et al. Comparison of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis adhesive properties and pathogenicity. Int. J. Med. Microbiol. 2013, 303:98-103.
4. Bourgeois C., et al. Fungal attacks on mammalian hosts: pathogen elimination requires sensing and tasting. Curr. Opin. Microbiol. 2010, 13:401-408.
5. Cisterna R., et al. Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain. J. Clin. Microbiol. 2010, 48:4200-4206.
6. Clerihew L., et al. Candida parapsilosis infection in very low birthweight infants. Arch. Dis. Child. Fetal Neonatal Ed. 2007, 92. F127-9.
7. Cummings C.A., Relman D.A. Using DNA microarrays to study host-microbe interactions. Emerg. Infect. Dis. 2000, 6:513-525.
8. Dementhon K., et al. Development of an in vitro model for the multi-parametric quantification of the cellular interactions between Candida yeasts and phagocytes. PLoS ONE 2012, 7:e32621.
9. Gacser A., et al. Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. J. Clin. Invest. 2007, 117:3049-3058.
10. Heidenreich S., et al. Infection by Candida albicans inhibits apoptosis of human monocytes and monocytic U937 cells. J. Leukoc. Biol. 1996, 60:737-743.
11. Horasan E.S., et al. Increase in Candida parapsilosis fungemia in critical care units: a 6-years study. Mycopathologia 2010, 170:263-268.
12. Huang da W., et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
13. Kassu A., et al. Decreased 4-1BB expression on HIV-specific CD4+ T cells is associated with sustained viral replication and reduced IL-2 production. Clin. Immunol. 2009, 132:234-245.
14. Kim H.S., et al. Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect. Immun. 2005, 73:3714-3724.
15. Kwon B.S., et al. Immune responses in 4-1BB (CD137)-deficient mice. J. Immunol. 2002, 168:5483-5490.
16. Lee S.C., et al. 4-1BB (CD137) is required for rapid clearance of Listeria monocytogenes infection. Infect. Immun. 2005, 73:5144-5151.
17. Lewis L.E., et al. Stage specific assessment of Candida albicans phagocytosis by macrophages identifies cell wall composition and morphogenesis as key determinants. PLoS Pathog. 2012, 8:e1002578.
18. Manger I.D., Relman D.A. How the host 'sees' pathogens: global gene expression responses to infection. Curr. Opin. Immunol. 2000, 12:215-218.
19. Marcil A., et al. Candida albicans killing by RAW 264.7 mouse macrophage cells: effects of Candida genotype, infection ratios, and gamma interferon treatment. Infect. Immun. 2002, 70:6319-6329.
20. Miliotis M.D. Acridine orange stain for determining intracellular enteropathogens in HeLa cells. J. Clin. Microbiol. 1991, 29:830-831.
21. Montagna M.T., et al. Invasive fungal infections in neonatal intensive care units of Southern Italy: a multicentre regional active surveillance (AURORA project). J. Prev. Med. Hyg. 2010, 51:125-130.
22. Netea M.G., et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin. Invest. 2006, 116:1642-1650.
23. Neu N., et al. Epidemiology of candidemia at a Children's hospital, 2002 to 2006. Pediatr. Infect. Dis. J. 2009, 28:806-809.
24. Pammi M., et al. Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis. Pediatr. Infect. Dis. J. 2013.
25. Peman J., et al. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 2005, 24:23-30.
26. Pfaller M.A., et al. Candida bloodstream infections: comparison of species distribution and antifungal resistance in community onset and nosocomial isolates in the SENTRY antimicrobial surveillance program (2008-2009). Antimicrob. Agents Chemother. 2010.
27. Seider K., et al. Interaction of pathogenic yeasts with phagocytes: survival, persistence and escape. Curr. Opin. Microbiol. 2010, 13:392-400.
28. Smith P.B., et al. Neonatal candidiasis. Infect. Dis. Clin. North Am. 2005, 19:603-615.
29. Németh Tibor, et al. Characterization of virulence properties in the Candida parapsilosis Sensu Lato species. PLoS ONE 2013, 8.
30. Tortorano A.M., et al. Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008). Mycoses 2011.
31. Trofa D., et al. Candida parapsilosis, an emerging fungal pathogen. Clin. Microbiol. Rev. 2008, 21:606-625.
32. van Asbeck E.C., et al. Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility. Crit. Rev. Microbiol. 2009, 35:283-309.
33. Van de Velde W., et al. Plant peptides govern terminal differentiation of bacteria in symbiosis. Science 2010, 327:1122-1126.
34. Vazquez N., et al. Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. Infect. Immun. 1998, 66:145-150.
35. Vinay D.S., Kwon B.S. 4-1BB signaling beyond T cells. Cell. Mol. Immunol. 2011, 8:281-284.
36. Vinay D.S., Kwon B.S. Immunotherapy of cancer with 4-1BB. Mol. Cancer Ther. 2012, 11:1062-1070.
37. Yoshikai Y., Nishimura H. The role of interleukin 15 in mounting an immune response against microbial infections. Microbes Infect. 2000, 2:381-389.
38. Zhou H., et al. Genome-wide RNAi screen in IFN-gamma-treated human macrophages identifies genes mediating resistance to the intracellular pathogen Francisella tularensis. PLoS ONE 2012, 7:e31752.